Radiomics for Predicting Response of Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

Abstract

PurposeThis study examined the methodological quality of radiomics to predict the effectiveness of neoadjuvant chemotherapy in nasopharyngeal carcinoma (NPC). We performed a meta-analysis of radiomics studies evaluating the bias risk and treatment response estimation.MethodsOur study was conducted through a literature review as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We included radiomics-related papers, published prior to January 31, 2022, in our analysis to examine the effectiveness of neoadjuvant chemotherapy in NPC. The methodological quality was assessed using the radiomics quality score. The intra-class correlation coefficient (ICC) was employed to evaluate inter-reader reproducibility. The pooled area under the curve (AUC), pooled sensitivity, and pooled specificity were used to assess the ability of radiomics to predict response to neoadjuvant chemotherapy in NPC. Lastly, the Quality Assessment of Diagnostic Accuracy Studies technique was used to analyze the bias risk.ResultsA total of 12 studies were eligible for our systematic review, and 6 papers were included in our meta-analysis. The radiomics quality score was set from 7 to 21 (maximum score: 36). There was satisfactory ICC (ICC = 0.987, 95% CI: 0.957–0.996). The pooled sensitivity and specificity were 0.88 (95% CI: 0.71–0.95) and 0.82 (95% CI: 0.68–0.91), respectively. The overall AUC was 0.91 (95% CI: 0.88–0.93).ConclusionPrediction response of neoadjuvant chemotherapy in NPC using machine learning and radiomics is beneficial in improving standardization and methodological quality before applying it to clinical practice.

Predicting Extrathyroidal Extension in Papillary Thyroid Carcinoma Using a Clinical-Radiomics Nomogram Based on B-Mode and Contrast-Enhanced Ultrasound

“…The biological behavior and molecular biology associated with cancer are usually known via biopsies, which are invasive; in contrast, radiomics can be exploited as a rapid, cost-effective, and non-invasive imaging biomarker [38][39][40], and it may offer a promising alternative to biopsies for assessing tumors, such as those observed in breast cancer [41,42], thyroid cancer [43], and prostate cancer [44]. In addition, radiomics can overcome the subjectivity of traditional image diagnoses and provide quantitative imaging features [45][46][47], opening up a new tumor-imaging landscape [48]. Previous studies have shown that radiomics can be used to predict the ETE in PTC.…”

MRI-based clinical radiomics nomogram may predict the early response after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma

“…In addition, the simple radiomics model also provided a better AUC than the clinical model (0.76 vs. 0.60, p =0.03) ( 35 ). According to a meta-analysis, there is evidence to suggest that radiomics is a successful method for predicting the response to neoadjuvant chemotherapy in patients with NPC ( 36 ). Our paper further supports the validity of radiomics in predicting therapeutic response to NPC.…”

Clinical‑imaging‑radiomic nomogram based on unenhanced CT effectively predicts adrenal metastases in patients with lung cancer with small hyperattenuating adrenal incidentalomas

“…Radiomics can extract larger numbers of objective and quantitative image-related features from CT images. These features encompass texture, geometry and intensity, offering insights into tumor heterogeneity and enabling the exploration of potential correlations between pathophysiology and biomedical images (20,21). A combined radiomic model incorporating radiomic features with relevant clinical and imaging features, as a complex bioinformatics mining tool, may improve the accuracy of differential diagnosis, classification and prediction (22,23).…”